Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts

被引:43
作者
Cecchi, Cristina
Fiorillo, Claudia
Baglioni, Serena
Pensalfini, Anna
Bagnoli, Silvia
Nacmias, Benedetta
Sorbi, Sandro
Nosi, Daniele
Relini, Annalisa
Liguri, Gianfranco
机构
[1] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy
[2] Univ Florence, Dept Anat Histol & Forens Med, I-50134 Florence, Italy
[3] Univ Florence, Dept Neurol & Psychiat Sci, I-50139 Florence, Italy
[4] Univ Genoa, Dept Phys, I-16146 Genoa, Italy
关键词
familial Alzheimer's disease; APP and PS-1 genes; amyloid beta-peptide; fibroblasts; oxidative stress; antioxidant capacity; lipid peroxidation; amyloid aggregate toxicity;
D O I
10.1016/j.neurobiolaging.2006.05.014
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Much experimental evidence suggests that an imbalance in cellular redox status is a major factor in the pathogenesis of Alzheimer's disease (AD). Our previous data showed a marked increase in membrane lipoperoxidation in primary fibroblasts from familial AD (FAD) patients. In the present study, we demonstrate that when oligomeric structures of A beta 1-40 and A beta 1-42 are added to the culture media, they accumulate quicker near the plasma membrane, and are internalized faster and mostly in APPV717I fibroblasts than in age-matched healthy cells; this results in an earlier and sharper increase in the production of reactive oxygen species (ROS). Higher ROS production leads in turn to an increase in membrane oxidative-injury and significant impairment of cellular antioxidant capacity, giving rise to apoptotic cascade activation and finally to a necrotic outcome. In contrast, healthy fibroblasts appear more resistant to amyloid oxidative-attack, possibly as a result of their plasma membrane integrity and powerful antioxidant capacity. Our data are consistent with increasing evidence that prefibrillar aggregates, compared to mature fibrils, are likely the more toxic species of the peptides. These findings provide compelling evidence that cells bearing increased membrane lipoperoxidation are more susceptible to aggregate toxicity as a result of their reduced ability to counteract amyloid oligomeric attack. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:863 / 876
页数:14
相关论文
共 73 条
[1]  
American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU
[2]  
ANDERSON AJ, 1995, J NEUROCHEM, V65, P1487
[3]   AMYLOID-BETA PEPTIDE INDUCES NECROSIS RATHER THAN APOPTOSIS [J].
BEHL, C ;
DAVIS, JB ;
KLIER, FG ;
SCHUBERT, D .
BRAIN RESEARCH, 1994, 645 (1-2) :253-264
[4]   Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions:: Aggregation preventing transmembrane anchoring Versus accelerated surface fibril formation [J].
Bokvist, M ;
Lindström, F ;
Watts, A ;
Gröbner, G .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 335 (04) :1039-1049
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Prefibrillar amyloid protein aggregates share common features of cytotoxicity [J].
Bucciantini, M ;
Calloni, G ;
Chiti, F ;
Formigli, L ;
Nosi, D ;
Dobson, CM ;
Stefani, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (30) :31374-31382
[7]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[8]   Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells [J].
Burdick, D ;
Kosmoski, J ;
Knauer, MF ;
Glabe, CG .
BRAIN RESEARCH, 1997, 746 (1-2) :275-284
[9]   Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity:: Implications for neurodegeneration in Alzheimer's disease brain.: A review [J].
Butterfield, DA .
FREE RADICAL RESEARCH, 2002, 36 (12) :1307-1313
[10]   Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide [J].
Butterfield, DA ;
Drake, J ;
Pocernich, C ;
Castegna, A .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (12) :548-554